Herpes vaccine (Harvard Medical School/Acambis)

N/A

Report date: 2022/07/20 13:32:33

Base Information

Drug NameHerpes vaccine (Harvard Medical School/Acambis)
Drug Alias NameHerpes-simplex-vaccineHerpes-simplex-virus-2-vaccineHerpes-simplex-virus-vaccineHerpes-simplex- 2-vaccinedl5-29 HSV-2 vaccine +[10] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune DesignSanofi PasteurNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A